Günay S, Parlak IS, Hezer H, Şeref Parlak E Şengül, Umut MS, Hancıoğlu Z, Çelenk Ergüden H, Kocaman Y, Dalkıran A, Sertçelik Ümran, Şerifoğlu İrem, Akpınar E, Göktaş MF, Fidan M, Babahanoğlu B, Cander FS, Çıvgın E, Er M, Kılıç H, Argüder E, Tuğ T, Ünsal E, Hasanoğlu C, Günay İrem, Babayiğit M, Ağca B, Karalezli A. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2023 Sep. 13 [cited 2023 Dec. 5];40(3):e2023029. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/14418